Neuroendocrine studies with dopamine agonists in schizophrenia.
作者信息
Rotrosen J, Angrist B, Paquin J
出版信息
Psychopharmacol Bull. 1978 Jan;14(1):14-7.
PMID:625529
Abstract
摘要
相似文献
1
Neuroendocrine studies with dopamine agonists in schizophrenia.
Psychopharmacol Bull. 1978 Jan;14(1):14-7.
2
Neuroendocrine assessment of dopaminergic activity in schizophrenia.
Adv Biochem Psychopharmacol. 1977;16:649-53.
3
Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
Methods Find Exp Clin Pharmacol. 1985 Aug;7(8):451-4.
4
Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.
Psychopharmacology (Berl). 1976 Dec 21;51(1):1-7. doi: 10.1007/BF00426313.
5
Postsynaptic supersensitivity in schizophrenia.
Am J Psychiatry. 1977 May;134(5):518-22. doi: 10.1176/ajp.134.5.518.
6
Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
Biol Psychiatry. 1983 Feb;18(2):255-9.
7
A neuroendocrine study of supersensitivity in tardive dyskinesia.
Arch Gen Psychiatry. 1977 Oct;34(10):1199-203. doi: 10.1001/archpsyc.1977.01770220081009.
8
CNV and dopamine receptor reactivity: correlations with the apomorphine test.
Electroencephalogr Clin Neurophysiol Suppl. 1986;38:403-5.
9
Neuroendocrine function in schizophrenia.
Acta Psychiatr Belg. 1980 Jul-Aug;80(4):421-35.
10
Down-regulation of central dopamine receptors in schizophrenia.
Am J Psychiatry. 1985 Nov;142(11):1334-7. doi: 10.1176/ajp.142.11.1334.
引用本文的文献
1
Plasma growth hormone response to oral l-dopa in infantile autism.
J Autism Dev Disord. 1985 Jun;15(2):205-12. doi: 10.1007/BF01531606.
Zotero 插件